<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Stem Cell Res</journal-id><journal-id journal-id-type="iso-abbrev">Stem Cell Res</journal-id><journal-title-group><journal-title>Stem Cell Research</journal-title></journal-title-group><issn pub-type="ppub">1873-5061</issn><issn pub-type="epub">1876-7753</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27346000</article-id><article-id pub-id-type="pmc">4823665</article-id><article-id pub-id-type="publisher-id">S1873-5061(16)00014-3</article-id><article-id pub-id-type="doi">10.1016/j.scr.2016.01.004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Lab Resource: Stem Cell Line</subject></subj-group></article-categories><title-group><article-title>Generation of KCL018 research grade human embryonic stem cell line carrying a mutation in the <italic>DMPK</italic> gene</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Miere</surname><given-names>Cristian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hewitson</surname><given-names>Heema</given-names></name></contrib><contrib contrib-type="author"><name><surname>Devito</surname><given-names>Liani</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Victoria</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kadeva</surname><given-names>Neli</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cornwell</surname><given-names>Glenda</given-names></name></contrib><contrib contrib-type="author"><name><surname>Codognotto</surname><given-names>Stefano</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stephenson</surname><given-names>Emma</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ilic</surname><given-names>Dusko</given-names></name><email>dusko.ilic@kcl.ac.uk</email><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff id="af0005">Stem Cell Laboratories, Division of Women's Health, Faculty of Life Sciences and Medicine, King's College London and Assisted Conception Unit, Guys' Hospital, London, United Kingdom</aff><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author. <email>dusko.ilic@kcl.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>3</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>3</month><year>2016</year></pub-date><volume>16</volume><issue>2</issue><fpage>342</fpage><lpage>344</lpage><history><date date-type="received"><day>30</day><month>12</month><year>2015</year></date><date date-type="rev-recd"><day>5</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>12</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 University of Texas at Austin Dell Medical School</copyright-statement><copyright-year>2016</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract><p>The KCL018 human embryonic stem cell line was derived from an embryo donated for research that carried an autosomal dominant mutation affecting one allele of the <italic>DMPK</italic> gene encoding the dystrophia myotonica protein kinase (2200 trinucleotide repeats; 14 for the normal allele). The ICM was isolated using laser microsurgery and plated on &#x003b3;-irradiated human foreskin fibroblasts. Both the derivation and cell line propagation were performed in an animal product-free environment. Pluripotent state and differentiation potential were confirmed by in vitro assays.</p></abstract></article-meta></front><body><p>Resource table<table-wrap id="t0010" position="float"><table frame="hsides" rules="groups"><tbody><tr><td align="left">Name of stem cell line</td><td align="left">KCL018</td></tr><tr><td align="left">Institution</td><td align="left">King's College London, London UK</td></tr><tr><td align="left">Derivation team</td><td align="left">Neli Kadeva, Victoria Wood, Glenda Cornwell, Stefano Codognotto, Emma Stephenson</td></tr><tr><td align="left">Contact person and email</td><td align="left">Dusko Ilic, email: <ext-link ext-link-type="uri" xlink:href="mailto:dusko.ilic@kcl.ac.uk" id="ir0005">dusko.ilic@kcl.ac.uk</ext-link></td></tr><tr><td align="left">Type of resource</td><td align="left">Biological reagent: cell line</td></tr><tr><td align="left">Sub-type</td><td align="left">Human pluripotent stem cell line</td></tr><tr><td align="left">Origin</td><td align="left">Human embryo</td></tr><tr><td align="left">Key marker expression</td><td align="left">Pluripotent stem cell markers: NANOG, OCT4, TRA-1-60, TRA-1-81, alkaline phosphatase (AP) activity</td></tr><tr><td align="left">Authentication</td><td align="left">Identity and purity of line confirmed</td></tr><tr><td align="left">Link to related literature (direct URL links and full references)</td><td align="left"><list list-type="simple"><list-item id="o0005"><label>1)</label><p>Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson, D., Petrova, A., Kadeva, N., Codognotto, S., Patel, H., Semple, M., Cornwell, G., Ogilvie, C., Braude, P., 2012. Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy. 14 (1), 122&#x02013;128.</p></list-item></list>doi: 10.3109/14,653,249.2011.623692<break/><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22029654" id="ir0010">http://www.ncbi.nlm.nih.gov/pubmed/22029654</ext-link><break/><list list-type="simple"><list-item id="o0010"><label>2)</label><p>Stephenson, E., Jacquet, L., Miere, C., Wood, V., Kadeva, N., Cornwell, G., Codognotto, S., Dajani, Y., Braude, P., Ilic, D., 2012. Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat. Protoc. 7 (7), 1366&#x02013;1381.</p></list-item></list>doi: 10.1038/nprot.2012.080<break/><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22722371" id="ir0015">http://www.ncbi.nlm.nih.gov/pubmed/22722371</ext-link></td></tr><tr><td align="left">Information in public databases</td><td align="left">KCL018 is a National Institutes of Health (NIH) registered hESC line<break/>NIH Registration Number: 0218<break/>NIH Approval Number: NIHhESC-13-0218<break/><ext-link ext-link-type="uri" xlink:href="http://grants.nih.gov/stem_cells/registry/current.htm?id=658" id="ir0020">http://grants.nih.gov/stem_cells/registry/current.htm?id=658</ext-link></td></tr><tr><td align="left">Ethics</td><td align="left">The hESC line KCL018 is derived under license from the UK Human Fertilisation and Embryology Authority (research license numbers: R0075 and R0133) and also has local ethical approval (UK National Health Service Research Ethics Committee Reference: 06/Q0702/90).<break/>Informed consent was obtained from all subjects and the experiments conformed to the principles set out in the WMA Declaration of Helsinki and the NIH Belmont Report. No financial inducements are offered for donation.</td></tr></tbody></table></table-wrap></p><p>Resource details<table-wrap id="t0015" position="float"><table frame="hsides" rules="groups"><tbody><tr><td align="left">Consent signed</td><td align="left">Aug 12, 2009</td></tr><tr><td align="left">Embryo thawed</td><td align="left">Aug 23, 2009</td></tr><tr><td align="left">UK Stem Cell Bank Deposit Approval</td><td align="left">Sep 23, 2010<break/>Reference: SCSC10-30</td></tr><tr><td align="left">Sex</td><td align="left">Female 46, XX</td></tr><tr><td align="left">Grade</td><td align="left">Research</td></tr><tr><td align="left">Disease status<break/>(<xref rid="f0005" ref-type="fig">Fig. 1</xref>)</td><td align="left">Mutation affecting one allele of the <italic>DMPK</italic> gene encoding dystrophia myotonica protein kinase (~&#x000a0;2200 CTG repeats; 14 for the normal allele) associated with Myotonic dystrophy Type 1 (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>)</td></tr><tr><td align="left">Karyotype (aCGH)</td><td align="left">No copy number changes detected</td></tr><tr><td align="left">DNA fingerprint</td><td align="left">Allele sizes (in bp) of 17 microsatellite markers specific for chromosomes 13, 18 and 21 (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>)</td></tr><tr><td align="left">Viability testing</td><td align="left">Pass</td></tr><tr><td align="left">Pluripotent markers<break/>(immunostaining)<break/>(<xref rid="f0010" ref-type="fig">Fig. 2</xref>)</td><td align="left">NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>)</td></tr><tr><td align="left">Three germ layers differentiation in vitro<break/>(immunostaining)<break/>(<xref rid="f0015" ref-type="fig">Fig. 3</xref>)</td><td align="left">Endoderm: AFP (&#x003b1;-fetoprotein); Ectoderm: TUBB3 (tubulin, &#x003b2;3 class III); Mesoderm: ACTA2 (actin, &#x003b1;2, smooth muscle) (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>)</td></tr><tr><td align="left">Sibling lines available</td><td align="left">No</td></tr></tbody></table></table-wrap></p><p>We generated KCL018 clinical grade hESC line following protocols, established previously (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>, <xref rid="bb0020" ref-type="bibr">Stephenson et al., 2012</xref>). The expression of the pluripotency markers was tested after freeze/thaw cycle (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>). Differentiation potential into three germ layers was verified in vitro (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>).</p><sec id="s0005"><title>Materials and methods</title><sec id="s0010"><title>Consenting process</title><p>We distribute Patient Information Sheet (PIS) and consent form to the in vitro fertilization (IVF) patients if they opted to donate to research embryos that were stored for 5 or 10&#x000a0;years. They mail signed consent back to us and that might be months after the PIS and consent were mailed to them. If in the meantime new versions of PIS/consent are implemented, we do not send these to the patients or ask them to resign; the whole process is done with the version that was given them initially. The PIS/consent documents (PGD-V.6) were created on Aug. 10, 2007. HFEA Code of Practice that was in effect at the time of document creation: Edition 7 &#x02014; R.1 (<ext-link ext-link-type="uri" xlink:href="http://www.hfea.gov.uk/2999.html" id="ir0025">http://www.hfea.gov.uk/2999.html</ext-link>). The donor couple signed the consent on Oct. 15, 2009. HFEA Code of Practice that was in effect at the time of donor signature: Edition 8 &#x02014; R.1. HFEA Code of Practice Edition 7 &#x02014; R.1 was in effect until Dec. 09, 2007 and Edition 8 &#x02014; R.1 was in effect: Oct. 01, 2009&#x02013;Apr. 06, 2010.</p></sec><sec id="s0015"><title>Embryo culture and micromanipulation</title><p>Embryo culture and laser-assisted dissection of inner cell mass (ICM) were carried out as previously described in details (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>, <xref rid="bb0020" ref-type="bibr">Stephenson et al., 2012</xref>). The cellular area containing the ICM was then washed and transferred to plates containing mitotically inactivated human neonatal foreskin fibroblasts (HFF).</p></sec><sec id="s0020"><title>Cell culture</title><p>ICM plated on mitotically inactivated HFF were cultured as described (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>, <xref rid="bb0020" ref-type="bibr">Stephenson et al., 2012</xref>). TE cells were removed mechanically from outgrowth (<xref rid="bb0015" ref-type="bibr">Ilic et al., 2007</xref>, <xref rid="bb0010" ref-type="bibr">Ilic et al., 2010</xref>). hESC colonies were expanded and cryopreserved at the third passage.</p></sec><sec id="s0025"><title>Viability test</title><p>Straws with the earliest frozen passage (p. 2&#x02013;3) are thawed and new colonies are counted three days later. These colonies are then expanded up to passage 8, at which point cells were part frozen and part subjected to standard battery of tests (pluripotency markers, in vitro and in vivo differentiation capability, genetics, sterility, mycoplasma).</p></sec><sec id="s0030"><title>Pluripotency markers</title><p>Pluripotency was assessed using two different techniques: enzymatic activity assay [alkaline phosphatase (AP) assay] and immunostaining as described (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>, <xref rid="bb0020" ref-type="bibr">Stephenson et al., 2012</xref>).</p></sec><sec id="s0035"><title>Genotyping</title><p>DNA was extracted from hES cell cultures using a Chemagen DNA extraction robot according to the manufacturer's instructions. Amplification of polymorphic microsatellite markers was carried out as described (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>). Allele sizes were recorded to give a unique fingerprint of each cell line.</p></sec><sec id="s0040"><title>Array comparative genomic hybridization (aCGH)</title><p>aCGH was performed as described in details (<xref rid="bb0005" ref-type="bibr">Ilic et al., 2012</xref>).<table-wrap id="t0005" position="float"><table frame="hsides" rules="groups"><thead><tr><th align="left">Chr</th><th align="left">Marker</th><th align="left">Allele 1</th><th align="left">Allele 2</th></tr></thead><tbody><tr><td align="center">13</td><td align="center">D13S252</td><td align="center">299</td><td align="center">299</td></tr><tr><td align="center">D13S305</td><td align="center">443</td><td align="center">458</td></tr><tr><td align="center">D13S325</td><td align="center">289</td><td align="center">297</td></tr><tr><td align="center">D13S628</td><td align="center">429</td><td align="center">450</td></tr><tr><td align="center">D13S634</td><td align="center">397</td><td align="center">417</td></tr><tr><td align="center">18</td><td align="center">D18S386</td><td align="center">383</td><td align="center">386</td></tr><tr><td align="center">D18S390</td><td align="center">372</td><td align="center">372</td></tr><tr><td align="center">D18S391</td><td align="center">209</td><td align="center">217</td></tr><tr><td align="center">D18S535</td><td align="center">482</td><td align="center">486</td></tr><tr><td align="center">D18S819</td><td align="center">408</td><td align="center">424</td></tr><tr><td align="center">D18S976</td><td align="center">479</td><td align="center">479</td></tr><tr><td align="center">D18S978</td><td align="center">219</td><td align="center">219</td></tr><tr><td align="center">21</td><td align="center">D21S11</td><td align="center">244</td><td align="center">251</td></tr><tr><td align="center">D21S1409</td><td align="center">216</td><td align="center">224</td></tr><tr><td align="center">D21S1411</td><td align="center">308</td><td align="center">308</td></tr><tr><td align="center">D21S1435</td><td align="center">184</td><td align="center">188</td></tr><tr><td align="center">D21S1437</td><td align="center">331</td><td align="center">335</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="s0045"><title>Author disclosure statement</title><p>There are no competing financial interests in this study.</p></sec></body><back><ref-list><title>References</title><ref id="bb0005"><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Ilic</surname><given-names>D.</given-names></name><name><surname>Stephenson</surname><given-names>E.</given-names></name><name><surname>Wood</surname><given-names>V.</given-names></name><name><surname>Jacquet</surname><given-names>L.</given-names></name><name><surname>Stevenson</surname><given-names>D.</given-names></name><name><surname>Petrova</surname><given-names>A.</given-names></name><name><surname>Kadeva</surname><given-names>N.</given-names></name><name><surname>Codognotto</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>H.</given-names></name><name><surname>Semple</surname><given-names>M.</given-names></name><name><surname>Cornwell</surname><given-names>G.</given-names></name><name><surname>Ogilvie</surname><given-names>C.</given-names></name><name><surname>Braude</surname><given-names>P.</given-names></name></person-group><article-title>Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions</article-title><source>Cytotherapy</source><volume>14</volume><issue>1</issue><year>2012</year><fpage>122</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">22029654</pub-id></element-citation></ref><ref id="bb0010"><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Ilic</surname><given-names>D.</given-names></name><name><surname>Caceres</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Julian</surname><given-names>P.</given-names></name><name><surname>Foulk</surname><given-names>R.</given-names></name><name><surname>Krtolica</surname><given-names>A.</given-names></name></person-group><article-title>Effect of karyotype on successful human embryonic stem cell derivation</article-title><source>Stem Cells Dev.</source><volume>19</volume><issue>1</issue><year>2010</year><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">19485710</pub-id></element-citation></ref><ref id="bb0015"><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>Ilic</surname><given-names>D.</given-names></name><name><surname>Genbacev</surname><given-names>O.</given-names></name><name><surname>Krtolica</surname><given-names>A.</given-names></name></person-group><article-title>Derivation of hESC from intact blastocysts</article-title><source>Curr. Protoc. Stem Cell Biol.</source><year>2007</year><comment>(Chapter 1: Unit 1&#x000a0;A.2)</comment></element-citation></ref><ref id="bb0020"><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>E.</given-names></name><name><surname>Jacquet</surname><given-names>L.</given-names></name><name><surname>Miere</surname><given-names>C.</given-names></name><name><surname>Wood</surname><given-names>V.</given-names></name><name><surname>Kadeva</surname><given-names>N.</given-names></name><name><surname>Cornwell</surname><given-names>G.</given-names></name><name><surname>Codognotto</surname><given-names>S.</given-names></name><name><surname>Dajani</surname><given-names>Y.</given-names></name><name><surname>Braude</surname><given-names>P.</given-names></name><name><surname>Ilic</surname><given-names>D.</given-names></name></person-group><article-title>Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment</article-title><source>Nat. Protoc.</source><volume>7</volume><issue>7</issue><year>2012</year><fpage>1366</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">22722371</pub-id></element-citation></ref></ref-list><ack id="ac0005"><title>Acknowledgments</title><p>This work was supported by the <funding-source id="gts0005">UK Medical Research Council</funding-source> grants G0701172 and G0801061. We thank Dr. Yacoub Khalaf, Director of the Assisted Conception Unit of Guy's and St Thomas' NHS Foundation Trust and his staff for supporting the research program. We are especially indebted to Prof Peter Braude and to the patients who donated embryos.</p></ack></back><floats-group><fig id="f0005"><label>Fig. 1</label><caption><p>Genetic pedigree tree. The couple undergoing IVF had only on embryo in this particular cycle. The embryo carried the mutation and was donated for research.</p></caption><graphic xlink:href="gr1"/></fig><fig id="f0010"><label>Fig. 2</label><caption><p>Expression of pluripotency markers. Pluripotency is confirmed by immunostaining (Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin stress fibers, visualized with rhodamine-phalloidin (red), are present in both feeders and hES cell colonies, whereas AP activity (green) is detected only in hES cells. Scale bar, 50&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr2"/></fig><fig id="f0015"><label>Fig. 3</label><caption><p>Differentiation of three germ layers in vitro is confirmed by detection of markers: smooth muscle actin (red) for mesoderm, &#x003b2;-III tubulin (red) for ectoderm and &#x003b1;-fetoprotein (red) for endoderm. Nuclei are visualized with Hoechst 33,342 (blue). Scale bar, 50&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr3"/></fig></floats-group></article>